March 19, 2020 / 12:13 PM / 17 days ago

BRIEF-Bioxcel Therapeutics Provides An Update On Its Ongoing Phase 3 Serenity Trials

March 19 (Reuters) - BioXcel Therapeutics Inc:

* BIOXCEL THERAPEUTICS PROVIDES AN UPDATE ON ITS ONGOING PHASE 3 SERENITY TRIALS

* BIOXCEL THERAPEUTICS - CURRENTLY MAINTAINS PREVIOUS GUIDANCE THAT SERENITY I & II ARE EXPECTED TO BE COMPLETED BY MID-YEAR 2020

* BIOXCEL THERAPEUTICS - HAS NOT OBSERVED CHANGE IN ENROLLMENT RATES RESULTING FROM COVID-19 PANDEMIC

* BIOXCEL THERAPEUTICS - ON TRACK TO REPORT TOPLINE DATA FROM BOTH STUDIES IN MID-2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below